Biotechnology News

September 7, 2012 at 3:04 pm Leave a comment

Chemotherapy research gets critical investment

McMaster’s Anna Dvorkin-Gheva has received a $119,000 grant from the Canadian Breast Cancer Foundation to study drugs that can be combined with current chemotherapy to make it more effective. The post-doctoral fellow in the Department of Biochemistry and Biomedical Sciences was among eight McMaster researchers who received a total of nearly $1.8 million in grants from the foundation to support research projects and fellowships. Almost $10 million in grants was awarded across the province.

Click here for more.

Entry filed under: Uncategorized.

Biotechnology News Controversy: Is a science PhD a waste of time?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


biorad1

Bio-Rad Canada has sponsored the development of this site to advance the productivity of the Canadian Biotechnology sector and the fine people who work in it across the country.  We invite readers to contribute content: posters, tools, research and presentations, articles white papers, multimedia, music downloads and entertainment, conference announcements, videos. Please contact info@cbt20.ca for more information.

Bookmark and Share

Site developed by What If What Next(TM)

Follow us on Twitter


%d bloggers like this: